No connection

Search Results

ICUCW

BEARISH
$0.03 Live
SeaStar Medical Holding Corporation · NASDAQ
$0.02 52W Range $0.03
Overview AI Snowflake Price Valuation Profitability Growth Health Statements

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 12, 2026
Market cap
N/A
P/E
N/A
ROE
-295.2%
Profit margin
N/A
Debt/Equity
0.05
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
The company exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total failure across all fundamental health metrics. While revenue growth is nominally high (526.90%), it is completely offset by a catastrophic operating margin of -718.09% and a negative ROE of -295.15%. The stock is trading as a penny stock ($0.03) with a bearish technical trend and no analyst coverage. Despite a low debt-to-equity ratio, the lack of profitability and deterministic health scores suggest a high risk of insolvency or further dilution.

Key Strengths

High gross margin (95.70%) suggesting strong product pricing power
Significant year-over-year revenue growth (526.90%)
Low debt-to-equity ratio (0.05)
Strong current ratio (3.63) indicating short-term liquidity
Low Price-to-Book ratio (0.01)

Key Risks

Catastrophic Piotroski F-Score (0/9) indicating severe fundamental weakness
Extreme operational losses with an operating margin of -718.09%
Severe equity erosion evidenced by -295.15% ROE
Penny stock volatility and lack of institutional analyst coverage
Bearish technical trend (10/100) and weak insider sentiment

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
12
Weak
Value
20
Future
30
Past
10
Health
0
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score of 0/9, Extreme negative operating margins, Penny stock status, Lack of earnings
Confidence
90%
Value
20/100

P/B is low, but without earnings or a Graham Number, the asset value is likely illiquid or impaired.

Positives
  • Very low P/B ratio (0.01)
Watchpoints
  • No P/E or Graham Number available
  • Value trap characteristics
Future
30/100

Revenue growth is high, but operating losses are scaling faster than sales.

Positives
  • Rapid revenue growth
Watchpoints
  • Unsustainable burn rate
  • No path to profitability shown in margins
Past
10/100

Historical trends show a stagnant stock price and failing fundamentals.

Positives
No standout positives identified.
Watchpoints
  • Consistent lack of profitability
  • Flat price performance over 1Y/3Y/5Y
Health
0/100

The 0/9 Piotroski score is a definitive signal of financial instability.

Positives
  • Low debt
Watchpoints
  • Piotroski F-Score 0/9
  • Negative ROA/ROE
Dividend
0/100

Dividend strength is 0/100.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • No capacity to pay

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.03

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ICUCW and closest competitors.

Updated 2026-04-10
ICU
SeaStar Medical Holding Corporation
Primary
5Y
0.0%
3Y
0.0%
1Y
0.0%
6M
0.0%
1M
+1.0%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.01
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin -718.1%
Gross Margin 95.7%
ROE -295.15%
ROA -80.88%

Growth

Revenue and earnings growth rates

Revenue Growth +526.9%
Earnings Growth N/A
Q/Q Revenue Growth +526.87%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.05
Low debt
Current Ratio
3.63
Strong
Quick Ratio
3.27
Excellent
Cash/Share
$3.0

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
97.1%
Op. Margin
-718.1%
Net Margin
-691.4%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.36x
Operating CF
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
100%

Past News Coverage

Recent headlines mentioning ICUCW from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile